Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7894249rdf:typepubmed:Citationlld:pubmed
pubmed-article:7894249lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:7894249lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:7894249lifeskim:mentionsumls-concept:C0038432lld:lifeskim
pubmed-article:7894249lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:7894249lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:7894249lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:7894249lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:7894249lifeskim:mentionsumls-concept:C0205365lld:lifeskim
pubmed-article:7894249pubmed:issue4-5lld:pubmed
pubmed-article:7894249pubmed:dateCreated1995-4-27lld:pubmed
pubmed-article:7894249pubmed:abstractTextHepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes were investigated biochemically and pathologically. Biochemically, the contents of serum glucose and of serum and liver lipids increased while the content of liver glycogen decreased in SZ-induced diabetic mice. Histopathologically, hypertrophy of hepatocytes due to an increase in number of intracytoplasmic acidophilic granules was common to SZ-induced diabetic mice. Electron microscopically, these hepatocytes were characterized by a prominent increase in number of mitochondria showing normal structure, a marked decrease of glycogen granules and poorly developed rough endoplasmic reticulum, which were common to so-called oncocytic cells. In some SZ-induced diabetic mice, bile duct hyperplasia with an appearance of cytomegalic hepatocytes was also observed.lld:pubmed
pubmed-article:7894249pubmed:languageenglld:pubmed
pubmed-article:7894249pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7894249pubmed:citationSubsetIMlld:pubmed
pubmed-article:7894249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7894249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7894249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7894249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7894249pubmed:statusMEDLINElld:pubmed
pubmed-article:7894249pubmed:monthOctlld:pubmed
pubmed-article:7894249pubmed:issn0940-2993lld:pubmed
pubmed-article:7894249pubmed:authorpubmed-author:DoiKKlld:pubmed
pubmed-article:7894249pubmed:authorpubmed-author:TamuraKKlld:pubmed
pubmed-article:7894249pubmed:authorpubmed-author:ItagakiSSlld:pubmed
pubmed-article:7894249pubmed:authorpubmed-author:OhmachiYYlld:pubmed
pubmed-article:7894249pubmed:authorpubmed-author:KumpJJlld:pubmed
pubmed-article:7894249pubmed:issnTypePrintlld:pubmed
pubmed-article:7894249pubmed:volume46lld:pubmed
pubmed-article:7894249pubmed:ownerNLMlld:pubmed
pubmed-article:7894249pubmed:authorsCompleteYlld:pubmed
pubmed-article:7894249pubmed:pagination368-74lld:pubmed
pubmed-article:7894249pubmed:dateRevised2006-10-30lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:meshHeadingpubmed-meshheading:7894249-...lld:pubmed
pubmed-article:7894249pubmed:year1994lld:pubmed
pubmed-article:7894249pubmed:articleTitleHepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes.lld:pubmed
pubmed-article:7894249pubmed:affiliationResearch Laboratory of Drug Metabolism, Tanabe Seiyaku Co. Ltd., Saitama, Japan.lld:pubmed
pubmed-article:7894249pubmed:publicationTypeJournal Articlelld:pubmed